TEST BANK
•
RAU s Respiratory Care Pharmacology
’
•
9TH EDITION
•
• BY GARDENHIRE
•
•
•
Test Bank for Rau s Respiratory Care Pharmacology 9th Edition Gardenhire
’
•
•
•
Test Bank for Rau s Respiratory Care Pharmacology, 9th Edition,
’
•
Gardenhire, ISBN-10:0323299687, ISBN-13: 9780323299688
•
•
Table of Contents
•
•
•
Unit I: Basic Concepts and Principles in Pharmacology
•
•
1. Introduction to Respiratory Care Pharmacology
2. Principles of Drug Action
3. Administration of Aerosolized Agents
4. Calculating Drug Doses
5. The Central and Peripheral Nervous Systems
•
Unit II: Drugs Used to Treat the Respiratory System
•
, •
6. Adrenergic (Sympathomimetic) Bronchodilators
7. Anticholinergic (Parasympatholytic) Bronchodilators
8. Xanthines
9. Mucus-Controlling Drug Therapy
10. Surfactant Agents
11. Corticosteriods in Respiratory Care
12. Nonsteroidal Antiasthma Agents
13. Aerosolized Antiinfective Agents
14. Antimicrobial Agents
15. Cold and Cough Agents
16. Selected Agents of Pulmonary Value
17. Neonatal and Pediatric Aerosolized Drug Therapy
•
Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
•
•
18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
19. Diuretic Agents
20. Drugs Affecting the Central Nervous System
21. Vasopressors, Inotropes, and Antiarrythmic Agents
22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
23. Sleep and Sleep Pharmacology
•
Chapter 01: Introduction to Respiratory Care
•
Pharmacology Gardenhire: Rau s Respiratory Care
’
Pharmacology, 9th Edition
•
MULTIPLE
•
CHOICE
•
, What is the name of the receptor sites that are located in the peripheral vasculature, the
•
heart, bronchialmuscle, and bronchial blood vessels?
Beta 2 receptors c. Alpha receptors
•
Gamma receptors d. Beta 1 receptors
•
ANS: C
•
Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle,
•
and bronchial blood vessels.
•
PTS: 1
•
•
Which receptor site results in tachycardia, an increased potential for arrhythmias,
•
and an increasedcardiac output?
Beta 1 receptor c. Alpha receptor
•
Beta 2 receptor d. Delta receptor
•
ANS: A
•
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for
•
arrhythmias, andan increased cardiac output. In administering drugs to the pulmonary
system, stimulation of the beta-1sites is not desired. However, most respiratory
pharmacologic agents have some beta-1 stimulatory effect.
•
PTS: 1
•
•
Stimulation of the beta 2 receptors causes
•
peripheral vasoconstriction and mild bronchoconstriction in the lungs.
•
tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
•
bronchodilation.
•
peripheral vasodilation, bradycardia, and decreased cardiac output.
•
ANS: C
•
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
•
•
PTS: 1
•
•
Acetylcholine stimulates
•
the Vagus nerve.
•
the adrenergic receptors.
•
, the sympathetic nervous system.
•
the cholinergic receptors.
•
ANS: D
•
Acetylcholine stimulates the cholinergic receptors.
•
•
PTS: 1
•
•
What immunoglobulin antibody sensitizes the mast cell?
•
Leukotrienes c. Histamine
•
•
IgE d. Prostaglandins
•
ANS: B
•
The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the
•
antigen causes thedegranulation of the mast cell.
•
PTS: 1
•
•
Which of the following is caused by histamine release from the mast cells?
•
Bronchodilation
•
Increased bronchial gland secretion
•
Increased amount of mucus present in the airways
•
I and II only c. III only
•
II and III only d. I, II, III
•
ANS: B
•
Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity,
•
histamine
II) increases bronchial gland secretion, causing III) an increase in the amount of mucus
•
present in the airways. Histamine may also have an effect on vascular permeability
similar to the effect of- SRS-A.
•
PTS: 1
•
•
A sympathomimetic drug would cause
•
bronchodilation. c. Histamine release.
•
bronchoconstriction. d. Vagus nerve stimulation.
•
•
RAU s Respiratory Care Pharmacology
’
•
9TH EDITION
•
• BY GARDENHIRE
•
•
•
Test Bank for Rau s Respiratory Care Pharmacology 9th Edition Gardenhire
’
•
•
•
Test Bank for Rau s Respiratory Care Pharmacology, 9th Edition,
’
•
Gardenhire, ISBN-10:0323299687, ISBN-13: 9780323299688
•
•
Table of Contents
•
•
•
Unit I: Basic Concepts and Principles in Pharmacology
•
•
1. Introduction to Respiratory Care Pharmacology
2. Principles of Drug Action
3. Administration of Aerosolized Agents
4. Calculating Drug Doses
5. The Central and Peripheral Nervous Systems
•
Unit II: Drugs Used to Treat the Respiratory System
•
, •
6. Adrenergic (Sympathomimetic) Bronchodilators
7. Anticholinergic (Parasympatholytic) Bronchodilators
8. Xanthines
9. Mucus-Controlling Drug Therapy
10. Surfactant Agents
11. Corticosteriods in Respiratory Care
12. Nonsteroidal Antiasthma Agents
13. Aerosolized Antiinfective Agents
14. Antimicrobial Agents
15. Cold and Cough Agents
16. Selected Agents of Pulmonary Value
17. Neonatal and Pediatric Aerosolized Drug Therapy
•
Unit III: Critical Care, Cardiovascular, and Polysomnography Agents
•
•
18. Skeletal Muscle Relaxants (Neuromuscular Blocking Agents)
19. Diuretic Agents
20. Drugs Affecting the Central Nervous System
21. Vasopressors, Inotropes, and Antiarrythmic Agents
22. Drugs Affecting Circulation: Antihypertensives, Antianginals, Antithrombotics
23. Sleep and Sleep Pharmacology
•
Chapter 01: Introduction to Respiratory Care
•
Pharmacology Gardenhire: Rau s Respiratory Care
’
Pharmacology, 9th Edition
•
MULTIPLE
•
CHOICE
•
, What is the name of the receptor sites that are located in the peripheral vasculature, the
•
heart, bronchialmuscle, and bronchial blood vessels?
Beta 2 receptors c. Alpha receptors
•
Gamma receptors d. Beta 1 receptors
•
ANS: C
•
Alpha receptors are located in the peripheral vasculature, the heart, bronchial muscle,
•
and bronchial blood vessels.
•
PTS: 1
•
•
Which receptor site results in tachycardia, an increased potential for arrhythmias,
•
and an increasedcardiac output?
Beta 1 receptor c. Alpha receptor
•
Beta 2 receptor d. Delta receptor
•
ANS: A
•
Stimulation of the beta-1 receptors results in tachycardia, an increased potential for
•
arrhythmias, andan increased cardiac output. In administering drugs to the pulmonary
system, stimulation of the beta-1sites is not desired. However, most respiratory
pharmacologic agents have some beta-1 stimulatory effect.
•
PTS: 1
•
•
Stimulation of the beta 2 receptors causes
•
peripheral vasoconstriction and mild bronchoconstriction in the lungs.
•
tachycardia, an increased potential for arrhythmias, and an increased cardiac output.
•
bronchodilation.
•
peripheral vasodilation, bradycardia, and decreased cardiac output.
•
ANS: C
•
Stimulation of the beta-2 receptors in the lungs causes bronchodilation.
•
•
PTS: 1
•
•
Acetylcholine stimulates
•
the Vagus nerve.
•
the adrenergic receptors.
•
, the sympathetic nervous system.
•
the cholinergic receptors.
•
ANS: D
•
Acetylcholine stimulates the cholinergic receptors.
•
•
PTS: 1
•
•
What immunoglobulin antibody sensitizes the mast cell?
•
Leukotrienes c. Histamine
•
•
IgE d. Prostaglandins
•
ANS: B
•
The IgE (reagin) antibodies sensitize the mast cell. Repeated exposure to the
•
antigen causes thedegranulation of the mast cell.
•
PTS: 1
•
•
Which of the following is caused by histamine release from the mast cells?
•
Bronchodilation
•
Increased bronchial gland secretion
•
Increased amount of mucus present in the airways
•
I and II only c. III only
•
II and III only d. I, II, III
•
ANS: B
•
Histamine is also a potent bronchoconstrictor. In addition to its bronchoconstrictive activity,
•
histamine
II) increases bronchial gland secretion, causing III) an increase in the amount of mucus
•
present in the airways. Histamine may also have an effect on vascular permeability
similar to the effect of- SRS-A.
•
PTS: 1
•
•
A sympathomimetic drug would cause
•
bronchodilation. c. Histamine release.
•
bronchoconstriction. d. Vagus nerve stimulation.
•
